MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: DIAGNOSTIC MARKERS AND FEATURES OF PHARMACOTHERAPY

Relevance. In 2020, children were hospitalized with fever and multisystem inflammation throughout the world during the COVID-19 pandemic. In the United States, this condition is called MIS-C (Multisystem Inflammatory Syndrome in Children). This syndrome is thought to be similar to the severe course...

Full description

Bibliographic Details
Main Authors: M.V. Кhaitovych, L.M. Voroniuk, G.Yu. Borisova, N.V. Diudenko, N.M. Miagka
Format: Article
Language:English
Published: Bogomolets National Medical University 2021-03-01
Series:Медична наука України
Subjects:
Online Access:https://msu-journal.com/index.php/journal/article/view/261